Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial is evaluating the safety and efficacy of adalimumab in mucopolysaccharidosis types I, II, and VI; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis Type
• Mucopolysaccharidosis Type Ii
• Mucopolysaccharidosis Type Vi

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Conditions: Mucopolysaccharidosis I, Mucopolysaccharidosis II | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING